A comprehensive view of non-vaccine biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Ricoh acquires majority stake in biotechnology firm Elixirgen Scientific to accelerate mRNA and personalized drug discovery using Elixirgen’s IPS cell technology; companies to start business predicting drug responses, disease mechanisms using AI
Published: May 19, 2022 by Ricoh Co.
Mimedex Q1 net loss widens to US$10.5M from loss of US$8.4M a year ago, with net sales down at US$58.9M from US$60.0M a year ago; advanced wound care up 13% year-over-year, as company gains traction in under-penetrated surgical recovery/tissues market
Published: May 09, 2022 by MiMedx Group Inc.
TaiMed starts Phase 3 clinical trial of Trogarzo IM injectable HIV drug for multi-drug-resistant patients after reaching agreement with Theratechnologies; Theratechnologies may enroll additional patients in study
Published: May 09, 2022 by Contify Life Science News
FDA approves Ilya Pharma’s IND for ILP100-Topical immunotherapy surgical wound treatment for patients with prediabetes, diabetes, obesity; company accelerating plans for Phase 2 study, with patients in study having increased risk of wound complications
Published: May 06, 2022 by Canada Newswire
FDA suspends early-stage clinic trial of Vertex’s VX-880 stem-cell therapy to potentially cure type 1 diabetes for ‘insufficient information’ to approve increased dose in tests; Vertex hopes continuing studies in Canada will assuage FDA concerns
Published: May 05, 2022 by The Boston Globe

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count